COV Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Covalon Technologies Ltd - Alpha Spread

Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.25 CAD Market Closed
Market Cap: 80.2m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Wall Street
Price Targets

COV Price Targets Summary
Covalon Technologies Ltd

Wall Street analysts forecast COV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COV is 8 CAD .

Lowest
Price Target
Not Available
Average
Price Target
8 CAD
146% Upside
Highest
Price Target
Not Available
Covalon Technologies Ltd Competitors:
Price Targets
PRTC
PureTech Health PLC
243% Upside
DVYSR
Devyser Diagnostics AB
6% Upside
2256
Abbisko Cayman Ltd
277% Upside
TRDA
Entrada Therapeutics Inc
61% Upside
GTHX
G1 Therapeutics Inc
2% Upside
PROB
Probi AB
19% Downside
NIOX
Niox Group PLC
21% Upside
GNFT
Genfit SA
142% Upside

Revenue
Forecast

Revenue Estimate
Covalon Technologies Ltd

Revenue forecast
is not available for
Covalon Technologies Ltd

Operating Income
Forecast

Operating Income Estimate
Covalon Technologies Ltd

Operating Income forecast
is not available for
Covalon Technologies Ltd

Net Income
Forecast

Net Income Estimate
Covalon Technologies Ltd

Net Income forecast
is not available for
Covalon Technologies Ltd

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is COV's stock price target?
Price Target
8 CAD

According to Wall Street analysts, the average 1-year price target for COV is 8 CAD .

Back to Top